Xiyuan Zhou

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Epithelial Mesenchymal Transition

Signaling Pathway

Top Venues

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Xinke Chen, Lijuan Ouyang, Ning Ke, Lianhong Pi, Xiyuan Zhou
Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3. Drug development research 85 (5) (2024)
Xinke Chen, Lijuan Ouyang, Ning Ke, Lianhong Pi, Xiyuan Zhou
Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3. Drug development research 85 (5) (2024)